Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Terrapin Technologies obtains rights to Walter Reed compound library

Dec. 16, 1996

Visible Genetics acquires BIOS Laboratories technology

Dec. 13, 1996

Myriad Genetics announces research collaboration

Dec. 13, 1996

CEPRATE SC approved for marketing in U.S.

Dec. 12, 1996

Drugs quicker to reach market in U.S. than in Germany and Japan

Dec. 12, 1996

Signal acquires rights to novel signaling proteins

Dec. 11, 1996

GenPharm generates human anti-IL-8 antibodies

Dec. 5, 1996

New patient-activated drug delivery system from Medtronic released in Europe

Dec. 5, 1996

Sterinetics System successfully inactivates multiple viruses in IVIg

Dec. 5, 1996

RTP to accelerate development of insoluble drug delivery technology

Dec. 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...